This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1g9v

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1g9v.gif|left|200px]]<br />
+
[[Image:1g9v.gif|left|200px]]<br /><applet load="1g9v" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1g9v" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1g9v, resolution 1.85&Aring;" />
caption="1g9v, resolution 1.85&Aring;" />
'''HIGH RESOLUTION CRYSTAL STRUCTURE OF DEOXY HEMOGLOBIN COMPLEXED WITH A POTENT ALLOSTERIC EFFECTOR'''<br />
'''HIGH RESOLUTION CRYSTAL STRUCTURE OF DEOXY HEMOGLOBIN COMPLEXED WITH A POTENT ALLOSTERIC EFFECTOR'''<br />
==Overview==
==Overview==
-
The crystal structure of human deoxy hemoglobin (Hb) complexed with a, potent allosteric effector, (2-[4-[[(3,5-dimethylanilino)carbonyl]methyl]phenoxy]-2-methylpropionic, acid) = RSR-13) is reported at 1.85 A resolution. Analysis of the, hemoglobin:effector complex indicates that two of these molecules bind to, the central water cavity of deoxy Hb in a symmetrical fashion, and that, each constrains the protein by engaging in hydrogen bonding and, hydrophobic interactions with three of its four subunits. Interestingly, we also find that water-mediated interactions between the bound effectors, and the protein make significant contributions to the overall binding., Physiologically, the interaction of RSR-13 with Hb results in increased, oxygen delivery to peripheral tissues. Thus, this compound has potential, therapeutic application in the treatment of hypoxia, ischemia, and, trauma-related blood loss. Currently, RSR-13 is in phase III clinical, trials as a radiosensitizing agent in the treatment of brain tumors. A, detailed structural analysis of this compound complexed with deoxy Hb has, important implications for the rational design of future analogs.
+
The crystal structure of human deoxy hemoglobin (Hb) complexed with a potent allosteric effector (2-[4-[[(3,5-dimethylanilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid) = RSR-13) is reported at 1.85 A resolution. Analysis of the hemoglobin:effector complex indicates that two of these molecules bind to the central water cavity of deoxy Hb in a symmetrical fashion, and that each constrains the protein by engaging in hydrogen bonding and hydrophobic interactions with three of its four subunits. Interestingly, we also find that water-mediated interactions between the bound effectors and the protein make significant contributions to the overall binding. Physiologically, the interaction of RSR-13 with Hb results in increased oxygen delivery to peripheral tissues. Thus, this compound has potential therapeutic application in the treatment of hypoxia, ischemia, and trauma-related blood loss. Currently, RSR-13 is in phase III clinical trials as a radiosensitizing agent in the treatment of brain tumors. A detailed structural analysis of this compound complexed with deoxy Hb has important implications for the rational design of future analogs.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1G9V is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SO4, HEM and RQ3 as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1G9V OCA].
+
1G9V is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=SO4:'>SO4</scene>, <scene name='pdbligand=HEM:'>HEM</scene> and <scene name='pdbligand=RQ3:'>RQ3</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1G9V OCA].
==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Abraham, D.J.]]
+
[[Category: Abraham, D J.]]
-
[[Category: Burnett, J.C.]]
+
[[Category: Burnett, J C.]]
-
[[Category: Joshi, G.S.]]
+
[[Category: Joshi, G S.]]
-
[[Category: Moure, C.M.]]
+
[[Category: Moure, C M.]]
-
[[Category: Safo, M.K.]]
+
[[Category: Safo, M K.]]
[[Category: HEM]]
[[Category: HEM]]
[[Category: RQ3]]
[[Category: RQ3]]
Line 29: Line 28:
[[Category: t state]]
[[Category: t state]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:02:07 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:47:50 2008''

Revision as of 10:47, 21 February 2008


1g9v, resolution 1.85Å

Drag the structure with the mouse to rotate

HIGH RESOLUTION CRYSTAL STRUCTURE OF DEOXY HEMOGLOBIN COMPLEXED WITH A POTENT ALLOSTERIC EFFECTOR

Contents

Overview

The crystal structure of human deoxy hemoglobin (Hb) complexed with a potent allosteric effector (2-[4-[[(3,5-dimethylanilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid) = RSR-13) is reported at 1.85 A resolution. Analysis of the hemoglobin:effector complex indicates that two of these molecules bind to the central water cavity of deoxy Hb in a symmetrical fashion, and that each constrains the protein by engaging in hydrogen bonding and hydrophobic interactions with three of its four subunits. Interestingly, we also find that water-mediated interactions between the bound effectors and the protein make significant contributions to the overall binding. Physiologically, the interaction of RSR-13 with Hb results in increased oxygen delivery to peripheral tissues. Thus, this compound has potential therapeutic application in the treatment of hypoxia, ischemia, and trauma-related blood loss. Currently, RSR-13 is in phase III clinical trials as a radiosensitizing agent in the treatment of brain tumors. A detailed structural analysis of this compound complexed with deoxy Hb has important implications for the rational design of future analogs.

Disease

Known diseases associated with this structure: Erythremias, alpha- OMIM:[141800], Erythremias, beta- OMIM:[141900], Erythrocytosis OMIM:[141850], HPFH, deletion type OMIM:[141900], Heinz body anemia OMIM:[141850], Heinz body anemias, alpha- OMIM:[141800], Heinz body anemias, beta- OMIM:[141900], Hemoglobin H disease OMIM:[141850], Hypochromic microcytic anemia OMIM:[141850], Methemoglobinemias, alpha- OMIM:[141800], Methemoglobinemias, beta- OMIM:[141900], Sickle cell anemia OMIM:[141900], Thalassemia, alpha- OMIM:[141850], Thalassemia-beta, dominant inclusion-body OMIM:[141900], Thalassemias, alpha- OMIM:[141800], Thalassemias, beta- OMIM:[141900]

About this Structure

1G9V is a Protein complex structure of sequences from Homo sapiens with , and as ligands. Full crystallographic information is available from OCA.

Reference

High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector., Safo MK, Moure CM, Burnett JC, Joshi GS, Abraham DJ, Protein Sci. 2001 May;10(5):951-7. PMID:11316875

Page seeded by OCA on Thu Feb 21 12:47:50 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools